After treatment initiation, the three groups significantly differentiated over time, with a clear trend given by a sharp decrease in disease activity parameters, which was particularly evident when the reference Group 1 was compared with the other two groups.
← all excerpts
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
2
—
—
The sentences
A statistically significant trend over time can be recognized from month 4 especially between Group 1 (CR yes-TF no-PDN off) and Group 3 (CR no-TF yes-PDN on or off), in particular for MD global, parent global, DAS, CMAS, MMT (all p values < 0.001) and CHAQ (p value = 0.002), with the exception of PhS that is very close to statistical significance and starts to be significant from month 12 onward.